Lisanti Capital Growth, LLC Myriad Genetics Inc Transaction History

Lisanti Capital Growth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$27.23 - $45.56 $1.31 Million - $2.2 Million	-48,225 Closed	0 $0
Q3 2018 Nov 05, 2018	BUY	$37.57 - $50.34 $1.81 Million - $2.43 Million	48,225 New	48,225 $2.22 Million
Q4 2017 Feb 07, 2018	SELL	$28.45 - $37.14 $1.31 Million - $1.71 Million	-46,150 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$24.01 - $36.2 $1.11 Million - $1.67 Million	46,150	46,150 $1.67 Million

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.31B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Lisanti Capital Growth, LLC, based on Form 13F filings with the SEC.

Stay updated on Lisanti Capital Growth, LLC with notifications on news.